| # | Title | Journal | Year | Citations |
|---|
| 1 | Myocarditis in the Setting of Cancer Therapeutics | Circulation | 2019 | 278 |
| 2 | JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis | Brain | 2018 | 169 |
| 3 | 239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018 | Neuromuscular Disorders | 2020 | 148 |
| 4 | Integrated classification of inflammatory myopathies | Neuropathology and Applied Neurobiology | 2017 | 92 |
| 5 | Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial | Lancet Neurology, The | 2019 | 91 |
| 6 | Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities | PLoS ONE | 2015 | 33 |
| 7 | Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept | PLoS ONE | 2022 | 29 |
| 8 | Gastrointestinal involvement in adult IgA vasculitis (Henoch-Schönlein purpura): updated picture from a French multicentre and retrospective series of 260 cases | Rheumatology | 2020 | 23 |
| 9 | Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study | Ocular Immunology and Inflammation | 2018 | 21 |
| 10 | Efficacy and patient satisfaction in the use of subcutaneous immunoglobulin immunotherapy for the treatment of auto-immune neuromuscular diseases | Autoimmunity Reviews | 2018 | 18 |
| 11 | Anti-RNP antibodies delineate a subgroup of myositis: A systematic retrospective study on 46 patients | Autoimmunity Reviews | 2020 | 14 |
| 12 | Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard? | Journal of Neurology | 2021 | 14 |
| 13 | Impact of aging on phenotype and prognosis in IgA vasculitis | Rheumatology | 2021 | 9 |
| 14 | Expanding the spectrum of HIV-associated myopathy | Journal of Neurology, Neurosurgery and Psychiatry | 2019 | 7 |
| 15 | A descriptive study of IgG4-related disease in children and young adults | Autoimmunity Reviews | 2022 | 7 |
| 16 | Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or during COVID-19 | Biomedicines | 2022 | 7 |
| 17 | Peripheral neuropathy and livedoid vasculopathy | Journal of Neurology | 2022 | 6 |
| 18 | Correlation between Ultra-Wide-Field Retinal Imaging Findings and Vascular Supra-Aortic Changes in Takayasu Arteritis | Journal of Clinical Medicine | 2021 | 5 |
| 19 | Reply: A child with severe juvenile dermatomyositis treated with ruxolitinib | Brain | 2018 | 4 |
| 20 | Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort | European Journal of Gastroenterology and Hepatology | 2019 | 4 |
| 21 | Germinal Center T follicular helper (GC-Tfh) cell impairment in chronic HIV infection involves c-Maf signaling | PLoS Pathogens | 2021 | 4 |
| 22 | Women and Pregnancy in Thromboangiitis Obliterans | Journal of Vascular Research | 2021 | 2 |
| 23 | POS0254 EFFICACY OF APREMILAST IN THE TREATMENT OF ORAL ULCERS OF BEHÇET’S SYNDROME: RESULTS FROM THE EUROPEAN SUBGROUP OF RELIEF | Annals of the Rheumatic Diseases | 2021 | 2 |
| 24 | Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis | Brain | 2019 | 1 |
